cs.AINov 17, 2026

VITAL: A Framework for Validating Agentic AI in Pharmaceutical Drug Development and Clinical Trial Operations

Authors: Sandeep Burugupalli, Pedro Matos-Filipe, Andrea Hita Ardiaca, Adam Taylor, Alex Grigorenko, Natalia Jakubiak, Xin Yu, Raghav Mani, 

Organizations: AstraZeneca Boston. 35 Gatehouse Drive, Waltham, MA 02451, United States · AstraZeneca Barcelona. Avinguda de Roma, 81, 08029 Barcelona, Spain · AstraZeneca Cambridge. Francis Crick Avenue Cambridge Biomedical Campus Cambridge, CB2 0AA, United Kingdom · NVIDIA. 2788 San Tomas Expy, Santa Clara, CA 95051, United States · 

Abstract

Current assurance approaches do not establish whether evidence is sufficient to validate, monitor and govern agentic artificial intelligence (AI) within a pharmaceutical context of use. Plausible outputs may conceal failures in retrieval, reasoning, orchestration or human-control points, where reference standards are unavailable. We developed and operationalised VITAL (Validation by Intended use, Traceability, Autonomy and Lifecycle evidence), a validation framework for agents in clinical development, through landscape analysis, regulatory and standards mapping, expert interviews and multi-stakeholder refinement. VITAL integrates context of use, controls, behavioural validation and lifecycle evidence within a risk-adjusted framework. We applied VITAL across epidemiology and treatment-landscape analysis, site selection, enrolment rescue and trial-design trade-off support to translate autonomy, reversibility, transparency and patient impact into proportionate validation activities, evidence requirements and auditable reconstruction of system behaviour. VITAL may inform evidence requirements and lifecycle accountability for higher-risk pharmaceutical uses; evaluation should assess reproducibility across assessors, organisations and system configurations.

Figures & tables

Explore similar work

CardsList
  1. Beyond Component Testing: Validating Agentic AI Systems

    Jul 31, 2026Fabio Orazio Mirto, Luca D'Agati, Giuseppe Tricomi +4AI Agent EvaluationAI Agent Safety

  2. A Multi-Agent Framework for Interpreting Multivariate Physiological Time Series

    Mar 4, 2026Davide Gabrielli, Paola Velardi, Stefano Faralli +1Explainable Artificial IntelligenceMulti-Agent LLMs

  3. Measurement Without Validity: The Compounding Reliability Problem in Agentic AI Evaluation

    Aug 1, 2026William CabanInter-Rater ReliabilityAI Agent Evaluation